Form 4 for CRH CRH plc
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0000950170-25-033697 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | 2025-03-03 | CRH | Manifold Albert Jude | See Remarks | F - Tax | $102.93 | -116.4K | 187.6K | -38% | -$11.99M | |
| 2025-03-05 | 2025-03-03 | CRH | Manifold Albert Jude | See Remarks | M - OptEx | $0.00 | +25.9K | 304.0K | +9% | $0 | |
| 2025-03-05 | 2025-03-03 | CRH | Manifold Albert Jude | See Remarks | A - Grant | $0.00 | +198.0K | 278.1K | +247% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-03 | F | D | 116,446 | $102.93 | 187,572 | D | — | — | (F3) Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in connection with the aforementioned award. (F4) The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $102.30 and $103.535 inclusive of shares sold on the New York Stock Exchange. Full information regarding the number of Ordinary Shares sold at each separate price in the range will be provided to the SEC upon request. (F5) The Reporting Person retired from his position as Chief Executive Officer and as a member of the Board of Directors of the Issuer, effective December 31, 2024, and therefore a Form 3 was not filed in connection with the Issuer's transition to U.S. domestic issuer reporting status, effective January 1, 2025. |
| 2 | Common | Ordinary Shares | 2025-03-03 | M | A | 25,942 | $0.00 | 304,018 | D | — | — | (F2) Reflects the vesting and release of a 2022 time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee, a total of 25,942 shares vested on March 3, 2025, including the award of 2,172 additional Ordinary Shares as dividend equivalents. |
| 3 | Common | Ordinary Shares | 2025-03-03 | A | A | 197,993 | $0.00 | 278,076 | D | — | — | (F1) Reflects the vesting and release of awards granted in 2020 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 25,484 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee"). |